Literature DB >> 18199525

Acquired lymphedema: an urgent need for adequate animal models.

Catarina Hadamitzky1, Reinhard Pabst.   

Abstract

In cancer patients, the removal of tumor-draining lymph nodes during tumor resection can lead to acquired lymphedema. This disease, which is characterized by tissue swelling and increased risk of infection due to restricted lymph flow, lacks an effective treatment. Limitations to the design and conduct of randomized trials to date have limited the evaluation of proposed surgical techniques. As a result, animal models have provided an important research base. This review summarizes work in canine, rabbit, and rodent models of acquired lymphedema, focusing on arising limitations and potential applications.

Entities:  

Mesh:

Year:  2008        PMID: 18199525     DOI: 10.1158/0008-5472.CAN-07-2454

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Rhesus monkey is a new model of secondary lymphedema in the upper limb.

Authors:  Guojun Wu; Hao Xu; Wenhong Zhou; Xianshun Yuan; Zhe Yang; Qing Yang; Feng Ding; Zhigang Meng; Weili Liang; Chong Geng; Ling Gao; Xingsong Tian
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema.

Authors:  Jason C Gardenier; Geoffrey E Hespe; Raghu P Kataru; Ira L Savetsky; Jeremy S Torrisi; Gabriela D García Nores; Joseph J Dayan; David Chang; Jamie Zampell; Inés Martínez-Corral; Sagrario Ortega; Babak J Mehrara
Journal:  JCI Insight       Date:  2016-09-22

3.  Interaction between vascularized lymph node transfer and recipient lymphatics after lymph node dissection-a pilot study in a canine model.

Authors:  Hiroo Suami; Mario F Scaglioni; Katherine A Dixon; Ramesh C Tailor
Journal:  J Surg Res       Date:  2016-05-26       Impact factor: 2.192

4.  Aligned nanofibrillar collagen scaffolds - Guiding lymphangiogenesis for treatment of acquired lymphedema.

Authors:  Stanley G Rockson; John P Cooke; Ngan F Huang; Catarina Hadamitzky; Tatiana S Zaitseva; Magdalena Bazalova-Carter; Michael V Paukshto; Luqia Hou; Zachary Strassberg; James Ferguson; Yuka Matsuura; Rajesh Dash; Phillip C Yang; Shura Kretchetov; Peter M Vogt
Journal:  Biomaterials       Date:  2016-06-07       Impact factor: 12.479

5.  Validation of laser scanning confocal microscopy as a diagnostic method for lymphedema using a rat model.

Authors:  Song Jin; Changlian Zhang; YunJie Li; Sheng Li; Min Gao; Ting Wang; Lanbo Li; Guoren Yang; Yang Ou
Journal:  Lasers Med Sci       Date:  2020-08-06       Impact factor: 3.161

6.  Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy.

Authors:  Amy Baker; Harold Kim; John L Semple; Dan Dumont; Molly Shoichet; Dalia Tobbia; Miles Johnston
Journal:  Breast Cancer Res       Date:  2010-09-08       Impact factor: 6.466

7.  Modification of a rodent hindlimb model of secondary lymphedema: surgical radicality versus radiotherapeutic ablation.

Authors:  Hyung Sub Park; In Mok Jung; Geum Hee Choi; Soli Hahn; Young Sun Yoo; Taeseung Lee
Journal:  Biomed Res Int       Date:  2013-11-14       Impact factor: 3.411

Review 8.  Current Advancements in Animal Models of Postsurgical Lymphedema: A Systematic Review.

Authors:  Jerry F Hsu; Roy P Yu; Eloise W Stanton; Jin Wang; Alex K Wong
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-08-27       Impact factor: 4.947

9.  Lymphatic territories (lymphosomes) in a canine: an animal model for investigation of postoperative lymphatic alterations.

Authors:  Hiroo Suami; Shuji Yamashita; Miguel A Soto-Miranda; David W Chang
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

10.  Developing a Lower Limb Lymphedema Animal Model with Combined Lymphadenectomy and Low-dose Radiation.

Authors:  Chin-Yu Yang; Dung H Nguyen; Chih-Wei Wu; Yu-Hua Dean Fang; Ko-Ting Chao; Ketan M Patel; Ming-Huei Cheng
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.